Genextra S.p.A. is 10% Owner at INTERCEPT PHARMACEUTICALS, INC. (ICPT). They have made 7 open-market trades across 1 company since 2013, most recently 2020-08-17.
CIK 0001559515
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25.0M since 2018, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICPT | 5,235,512 | $99.5M |
Shares reported on the most recent Form 4, priced at the 2020-08-17 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 50% | 50% |
| Avg Move | -10.7% | -3.9% | -10.0% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICPT | SELL | 2020-08-13 | 2020-08-17 | $47.71 | $77.6M | +3.5% | -6.3% | -20.4% |
| ICPT | SELL | 2020-05-13 | 2020-05-15 | $84.60 | $100.8M | -15.8% | -10.4% | -40.0% |
| ICPT | SELL | 2018-11-29 | 2018-12-03 | $105.07 | $78.8M | -0.4% | -10.3% | -3.5% |
| ICPT | BUY | 2018-04-09 | 2018-04-09 | $64.00 | $25.0M | -2.0% | +2.0% | +33.4% |
| ICPT | SELL | 2014-04-09 | 2014-04-11 | $317.71 | $111.0M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2013-10-21 | 2013-10-23 | $62.50 | $7.8M | -17.1% | +1.2% | +1.2% |
| ICPT | SELL | 2013-10-15 | 2013-10-17 | $62.50 | $70.2M | -17.1% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.